Clinical Trial Update: A Phase 2 Trial Testing ZP1848 in Patients With SBS [Phase 2]

View source ↗

Summary

A Phase 2 trial of ZP1848 for Short Bowel Syndrome has completed, according to Zealand Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• ZP1848

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 2 | Status: COMPLETED